Loss of heterozygosity in serial plasma DNA samples during follow‐up of women with breast cancer

No abstract is available for this paper.

• Publication year

  2003

• Venue

  International Journal of Cancer

• Publication date

  2003-10-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.11333PMID 12918071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients

  2004cited by this paper
• Proteomic Patterns of Nipple Aspirate Fluids Obtained by SELDI-TOF: Potential for New Biomarkers to Aid in the Diagnosis of Breast Cancer

  2002cited by this paper
• Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

  2002cited by this paper
• Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas.

  2002cited by this paper
• Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors

  2002cited by this paper
• Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival.

  2002cited by this paper
• Detection of circulating breast tumor cells by differential expression of marker genes.

  2002cited by this paper
• High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood

  2001cited by this paper
• Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.

  2001cited by this paper
• Circulating breast cancer cells are frequently apoptotic.

  2001cited by this paper
• Epithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up.

  2001cited by this paper
• Circulating Nucleic Acids and Apoptosis

  2001cited by this paper
• Correspondence re: F. Coulet et al., Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis. Cancer Res., 60: 707-709, 2000.

  2001cited by this paper
• Microsatellite Alterations Detected in the Serum of Early Stage Breast Cancer Patients

  2001cited by this paper
• Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.

  2001cited by this paper
• DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

  2001cited by this paper
• Heterogeneous tumor clones as an explanation of discordance between plasma DNA and tumor DNA alterations

  2001cited by this paper
• DNA alterations in tumor scrapes vs. biopsies of squamous‐cell carcinomas of the head and neck

  2000cited by this paper
• Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.

  2000cited by this paper
• A genome-wide map showing common regions of loss of heterozygosity/allelic imbalance in breast cancer.

  2000cited by this paper
• PCR artifacts in LOH and MSI analysis of microdissected tumor cells.

  2000cited by this paper
• Microsatellite alterations plasma DNA of primary breast cancer patients.

  2000cited by this paper
• Microsatellite abnormalities in plasma of patients with breast carcinoma: concordance with the primary tumour.

  1999cited by this paper
• Presence of tumor DNA in plasma of breast cancer patients: clinicopathological correlations.

  1999cited by this paper
• Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.

  1999cited by this paper
• Genetically abnormal clones in histologically normal breast tissue.

  1998cited by this paper
• Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma.

  1998cited by this paper
• Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas.

  1997cited by this paper
• Microsatellite alterations in plasma DNA of small cell lung cancer patients

  1996cited by this paper
• Microsatellite alterations in serum DNA of head and neck cancer patients

  1996cited by this paper
• Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours.

  1995cited by this paper
• Microsatellite alterations as clonal markers for the detection of human cancer.

  1994cited by this paper
• [Plasma DNA level as a tumor marker in primary lung cancer].

  1990cited by this paper
• Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease

  1983cited by this paper
• Free DNA in the serum of cancer patients and the effect of therapy.

  1977cited by this paper

• Detection of Loss of Heterozygosity in cfDNA of Advanced EGFR- or KRAS-Mutated Non-Small-Cell Lung Cancer Patients

  2019cites this paper
• LOH at 6 q and 10 q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival

  2018cites this paper
• Detection of genetic alterations in cfDNA as a possible strategy to monitor the neoplastic progression of Barrett's esophagus

  2017cites this paper
• CNAPS in Therapy Monitoring

  2015cites this paper
• Genomic instability in South African breast cancer patients

  2013cites this paper
• Imaging , Diagnosis , Prognosis Loss of Heterozygosity at Tumor Suppressor Genes Detectable on FractionatedCirculating Cell-Free TumorDNA as Indicator of Breast Cancer Progression

  2012cites this paper
• LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival

  2012cites this paper
• Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression

  2012cites this paper
• Prognosis Loss of Heterozygosity at Tumor Suppressor Genes Detectable on FractionatedCirculating Cell-Free TumorDNA as Indicator of Breast Cancer Progression

  2012cites this paper
• Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease.

  2011cites this paper
• Molecular analysis of the polymorphisms of thymidylate synthase on cell‐free circulating DNA in blood of patients with advanced colorectal carcinoma

  2010cites this paper
• Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.

  2010cites this paper
• Circulating nucleic acids as a potential source for cancer biomarkers.

  2010cites this paper
• Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer

  2009cites this paper
• Analyse der freien zirkulierenden DNA von Prostatakarzinom-Patienten auf allelische Imbalance

  2009cites this paper
• Identification of loss of heterozygosity on circulating free DNA in peripheral blood of prostate cancer patients: potential and technical improvements.

  2008cites this paper
• Prostate Cancer: Detection of Free Tumor-Specific DNA in Blood and Bone Marrow

  2008cites this paper
• Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer

  2008cites this paper
• Circulating nucleic acids (CNAs) and cancer--a survey.

  2007cites this paper
• A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer

  2007cites this paper
• Detection of tumor‐specific DNA in blood and bone marrow plasma from patients with prostate cancer

  2007cites this paper
• Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma.

  2006cites this paper
• Quantitative detection of p53 mutations in plasma DNA from tobacco smokers.

  2006cites this paper
• Quantitative Multiplex Methylation-Specific PCR Assay for the Detection of Promoter Hypermethylation in Multiple Genes in Breast Cancer

  2004cites this paper